Search details
1.
Blood plasma derived extracellular vesicles (BEVs): particle purification liquid chromatography (PPLC) and proteomic analysis reveals BEVs as a potential minimally invasive tool for predicting response to breast cancer treatment.
Breast Cancer Res Treat
; 196(2): 423-437, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-36114323
2.
Sulindac Improves Stiffness and Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer.
Breast Cancer Res Treat
; 192(1): 113-122, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-35039952
3.
Reproducible automated breast density measure with no ionizing radiation using fat-water decomposition MRI.
J Magn Reson Imaging
; 48(4): 971-981, 2018 10.
Article
in English
| MEDLINE | ID: mdl-29630755
4.
A maximum-likelihood method to estimate a single ADC value of lesions using diffusion MRI.
Magn Reson Med
; 76(6): 1919-1931, 2016 12.
Article
in English
| MEDLINE | ID: mdl-26743234
5.
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.
Support Care Cancer
; 24(1): 447-455, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26335402
6.
A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515.
Blood
; 120(6): 1210-7, 2012 Aug 09.
Article
in English
| MEDLINE | ID: mdl-22734071
7.
Osteoclast inhibition in postmenopausal breast cancer: Is the evidence too strong to ignore?
Cancer
; 123(13): 2392-2394, 2017 07 01.
Article
in English
| MEDLINE | ID: mdl-28464216
8.
A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer.
Breast Cancer Res Treat
; 134(1): 13-20, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22198412
9.
Response to letter to the Editors-Safety of long-term denosumab therapy.
Support Care Cancer
; 25(2): 353-355, 2017 02.
Article
in English
| MEDLINE | ID: mdl-27885467
10.
Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach.
J Bone Oncol
; 34: 100423, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35378840
11.
Two fully automated data-driven 3D whole-breast segmentation strategies in MRI for MR-based breast density using image registration and U-Net with a focus on reproducibility.
Vis Comput Ind Biomed Art
; 5(1): 25, 2022 Oct 11.
Article
in English
| MEDLINE | ID: mdl-36219359
12.
Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.
Support Care Cancer
; 24(1): 457-458, 2016 01.
Article
in English
| MEDLINE | ID: mdl-26482379
13.
Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors.
Clin Cancer Res
; 27(20): 5660-5668, 2021 10 15.
Article
in English
| MEDLINE | ID: mdl-34112707
14.
Changes in body weight and metabolic indexes in overweight breast cancer survivors enrolled in a randomized trial of low-fat vs. reduced carbohydrate diets.
Nutr Cancer
; 62(8): 1142-52, 2010.
Article
in English
| MEDLINE | ID: mdl-21058203
15.
Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307.
J Natl Cancer Inst
; 112(7): 698-707, 2020 07 01.
Article
in English
| MEDLINE | ID: mdl-31693129
16.
Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer.
Dis Markers
; 2016: 9810383, 2016.
Article
in English
| MEDLINE | ID: mdl-26941473
17.
Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents.
Clin Cancer Res
; 22(23): 5713-5721, 2016 Dec 01.
Article
in English
| MEDLINE | ID: mdl-27140926
18.
Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models.
Leuk Lymphoma
; 56(5): 1432-9, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25130478
19.
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease.
Eur J Cancer
; 51(11): 1467-75, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25976743
20.
A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer.
Cancer Med
; 4(7): 1051-9, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25826750